Addyi Market Share Analysis for April 2026

Addyi® FDA-approved treatment for frustrating low libido in certain premenopausal women. PI, Med Guide, Safety & Boxed Warning re: low blood pressure & fainting in certain settings.

Health > Pharmacy

Domainaddyi.com

Year Founded2011

Employees51 - 200

Annual Revenue$10M - $15M

Addyi

Addyi (including company regionals)

addyi.com

See more website traffic and engagement information

Addyi Revenue up to April 2026 is 10M - 15M

revenue generated by Addyi top domains

Addyi top domains revenue over 3 years

Revenue for Addyi top domains

addyi.com10M - 15M

See more with Sales Intelligence

Total visits to Addyi's top domains

Understand Addyi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

addyi.com69.9K

See more with Sales Intelligence

Avg. visit duration in Addyi's top domains

Analyze Addyi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

addyi.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Addyi's top domains

See how Addyi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

addyi.com1.35

See more with Sales Intelligence

Addyi top competitors by domain

Top similar sites in April 2026, ranked by their affinity

vyleesi.comCompany NameVyleesiEmployees51 - 200HQUnited States, New Jersey, CranburyAnnual revenue$10M - $15MTotal visits27KHealth > Pharmacy

Top technologies used by Addyi

These are the website technologies, by industry, used by Addyi top domains

Advertising (23)

DoubleClick

Payment & Currencies (10)

Cart Functionality

Widget (8)

Twemoji

Conversion & Analytics (6)

Google Analytics

More Technologies

12

See all

News & Signals from Addyi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsValeant Pharmaceuticals acquires AddyiTM for $1B.The day after the FDA approval, Valeant acquired Addyi for $1 billion.

NewsAddyiTM launched telemedicine model on Jan 1st '18.In 2018, Sprout slashed its price in half and launched a new marketing strategy that included a telemedicine model designed to help prescribing.